BERLIN (Reuters) -German medical technology firm Brainlab is planning an initial public offering on the Frankfurt Stock Exchange in the coming weeks, the company said on Thursday. The Munich-based company said it will list on the regulated market and aims to raise up to 200 million euros ($230 million) through the issuance of new shares. Majority shareholder Stefan Vilsmeier, who founded the company 35 years ago and recently announced his retirement from the operational business, is set to continue to support the company as a long-term investor.Read More
